The FDA missed a 2nd deadline for submitting a proposal to the U.S. Congress detailing the user fees it will charge medical device makers to review their products.
The device industry and the federal watchdog agency have been haggling for months over the fees mandated by the Medical Device User Fee & Modernization Act, which is slated to be renewed this year.